Literature DB >> 19876066

Caspase-dependent generation of reactive oxygen species in human astrocytoma cells contributes to resistance to TRAIL-mediated apoptosis.

K Choi1, S-W Ryu, S Song, H Choi, S W Kang, C Choi.   

Abstract

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF family of cytokines, causes apoptosis by caspase activation in various cell types, particularly in transformed cells. Numerous types of tumors are relatively resistant to TRAIL-induced cytotoxicity; however, the reasons for this are not yet fully understood. We report here a new signal transduction pathway involving protein kinase Cdelta (PKCdelta), NADPH oxidase 4 (NOX4) and reactive oxygen species (ROS), that inhibits caspase-dependent cell death induced by TRAIL ligation in human malignant astrocytoma cells. In our experiments, TRAIL ligation-induced generation of intracellular ROS through caspase-dependent proteolytic activation of PKCdelta and subsequent activation of the NOX4 complex. Suppression of intracellular ROS induction using various pharmacological inhibitors or PKCdelta- or NOX4-specific RNA interference enhanced the enzymatic activity of caspase-3 by blocking the oxidative modification of its catalytic cysteine residue, resulting in marked augmentation of TRAIL-mediated cell death. These results collectively indicate that TRAIL-induced activation of PKCdelta and NOX4 can modulate TRAIL-mediated apoptosis by promoting oxidative modification of active caspase-3 in a negative-feedback manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19876066     DOI: 10.1038/cdd.2009.154

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  17 in total

Review 1.  Inflammation in the early stages of neurodegenerative pathology.

Authors:  Preeti J Khandelwal; Alexander M Herman; Charbel E-H Moussa
Journal:  J Neuroimmunol       Date:  2011-08-05       Impact factor: 3.478

2.  Endoplasmic reticulum stress sensor IRE1α propels neutrophil hyperactivity in lupus.

Authors:  Gautam Sule; Basel H Abuaita; Paul A Steffes; Andrew T Fernandes; Shanea K Estes; Craig Dobry; Deepika Pandian; Johann E Gudjonsson; J Michelle Kahlenberg; Mary X O'Riordan; Jason S Knight
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

Review 3.  Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery.

Authors:  Candice E Paulsen; Kate S Carroll
Journal:  Chem Rev       Date:  2013-03-20       Impact factor: 60.622

4.  The role of Bcl-xL in synergistic induction of apoptosis by mapatumumab and oxaliplatin in combination with hyperthermia on human colon cancer.

Authors:  Xinxin Song; Seog-Young Kim; Yong J Lee
Journal:  Mol Cancer Res       Date:  2012-10-10       Impact factor: 5.852

5.  Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase.

Authors:  H Choi; J-W Chang; Y-K Jung
Journal:  Cell Death Differ       Date:  2010-09-10       Impact factor: 15.828

Review 6.  Mechanosensitive Ion Channels: TRPV4 and P2X7 in Disseminating Cancer Cells.

Authors:  Jacob M Hope; Joshua D Greenlee; Michael R King
Journal:  Cancer J       Date:  2018 Mar/Apr       Impact factor: 3.360

7.  Caspase dependent programmed cell death in developing embryos: a potential target for therapeutic intervention against pathogenic nematodes.

Authors:  Alok Das Mohapatra; Sunil Kumar; Ashok Kumar Satapathy; Balachandran Ravindran
Journal:  PLoS Negl Trop Dis       Date:  2011-09-13

8.  Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells.

Authors:  Magdalena Dabrowska; Marek Skoneczny; Wojciech Rode
Journal:  Tumour Biol       Date:  2011-06-16

9.  TRAIL promotes caspase-dependent pro-inflammatory responses via PKCδ activation by vascular smooth muscle cells.

Authors:  S Song; K Choi; S-W Ryu; S W Kang; C Choi
Journal:  Cell Death Dis       Date:  2011-11-03       Impact factor: 8.469

10.  Identification of NCF2/p67phox as a novel p53 target gene.

Authors:  Dafne Italiano; Anna Maria Lena; Gerry Melino; Eleonora Candi
Journal:  Cell Cycle       Date:  2012-11-27       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.